A
Overview
Ascend Clinical provides laboratory testing nationwide, focusing on kidney disease and dialysis-related testing. It operates as a clinical reference laboratory offering comprehensive lab tests and environmental water testing (including Legionella), plus LabCheck, a web-based SaaS that helps dialysis clinics manage patient care. It differentiates itself with a 20+ year track record, a national footprint, and a mix of high-volume laboratory services with a dedicated software platform. Its goal is to deliver best-in-class lab services and tools to optimize patient care for dialysis clinics and their patients.
Work here?Claim your company
Simplify's Take
What believers are saying
- Eurofins closed the acquisition on April 3, 2024, expanding renal and transplant reach.
- Ascend's 170-person team and nationwide coverage support sticky dialysis-clinic relationships.
- Water and dialysate testing directly addresses CMS audits, AAMI ST108, and infection control.
What critics are saying
- Ascend's 2020 breach exposed 10,000-plus records, proving material cybersecurity weakness.
- Eurofins integration disrupts billing, service levels, and leadership continuity, pushing clinics to competitors.
- A second major data breach or CMS action forces dialysis clients to exit fast.
What makes Ascend Clinical unique
- Ascend is Eurofins' largest U.S. independent dialysis-testing platform, anchored in Sunnyvale.
- It combines 200-plus tests, 24-hour turnaround, and LabCheck ordering software.
- CONTINUUM links Ascend diagnostics with Eurofins Transplant Genomics for post-transplant care.
Help us improve and share your feedback! Did you find this helpful?